SION — SIONNA THERAPEUT

Ownership history in MARSHALL WACE, LLP  ·  2 quarters on record

This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in SIONNA THERAPEUT (SION). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 30,103 +17,915 +147.0% 0.00% $885K $29.41
2025 Q1 INITIATED 12,188 — — 0.00% $127K $10.46
% of Fund (quarterly)    SION price (monthly, adj. close)

Other funds also holding SION

As of 2025 Q4 — sorted by position size

Atlas Venture Life Science Advisors, LLC 3Y 14.24% TPG GP A, LLC 3Y 10.33% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 4.17% SUPERSTRING CAPITAL MANAGEMENT LP 3.98% ORBIMED ADVISORS LLC 3Y 7Y 2.99% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.86% Artia Global Partners LP 3Y 0.7% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 0.51% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 0.41% Soleus Capital Management, L.P. 3Y 0.41%
← Back to MARSHALL WACE, LLP Holdings